Antimalarika jako dvousečná zbraň u pacientů s rakovinou a infekcí COVID-19

Stáhnout PDF English version

Autoři: L. Mendoza
Působiště autorů: Hematology/ Oncology Unit, IQVIA Inc., Prague, Czech Republic
Vyšlo v časopise: Klin Onkol 2021; 34(4): 319-320
Kategorie: Short communications
doi: https://doi.org/10.48095/ccko2021319

Zdroje

1. Saini KS, Tagliamento M, Lambertini M et al. Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies. European Journal of Cancer 2020; 139: 43–50. doi: 10.1016/j.ejca.2020.08.011.

2. Plaquenil (hydroxychloroquine sulphate tables, USP). [online]. Available from: https: //www.accessdata.fda.gov/drugsatfda_docs/label/2017/009768s037s045s047lbl.pdf.

3. Mendoza L. Chloroquine and hydroxychloroquine for the treatment of COVID-19 patients: what every clinician should know. [online]. Available from: https: //papers.ssrn.com/sol3/papers.cfm?abstract_id=3713 810.

4. Piffoux M, Eriau E, Cassier PA. Autophagy as a therapeutic target in pancreatic cancer. Br J Cancer 2021; 124 (2): 333–344. doi: 10.1038/s41416-020-01039-5.

5. Towers CG, Thorburn A. Targeting the lysosome for cancer therapy. Cancer Discov 2017; 7 (11): 1218–1220. doi: 10.1158/2159-8290.

6. Rebecca VW, Nicastri MC, McLaughlin N et al. A unified approach to targeting the lysosome‘s degradative and growth signaling roles. Cancer Discov 2017; 7 (11): 1266–1283. doi: 10.1158/2159-8290.

7. Xu R, Ji Z, Xu C et al. The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: a systematic review and meta--analysis. Medicine (Baltimore) 2018; 97 (46): e12912. doi: 10.1097/MD.0000000000012912.

8. Warner JL, Rubinstein S, Grivas P et al. Clinical impact of COVID-19 on patients with cancer: data from the COVID-19 and Cancer Consortium (CCC19). [online]. Available from: https: //ascopubs.org/doi/10.1200/JCO.2020.38.18_suppl.LBA110.

9. Rogado J, Obispo B, Pangua C et al. Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid. [online]. Available from: https: //link.springer.com/article/ 10.1007/ s12094-020-02 381-z.